24,898 Shares in Solventum Corporation $SOLV Bought by White Pine Capital LLC

White Pine Capital LLC bought a new position in Solventum Corporation (NYSE:SOLV – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 24,898 shares of the company’s stock, valued at approximately $2,195,000.

Several other hedge funds also recently made changes to their positions in SOLV. Laurel Wealth Advisors LLC purchased a new stake in Solventum during the 3rd quarter valued at $29,000. JNBA Financial Advisors grew its holdings in Solventum by 71.9% in the 2nd quarter. JNBA Financial Advisors now owns 507 shares of the company’s stock worth $39,000 after acquiring an additional 212 shares during the last quarter. Ameritas Advisory Services LLC purchased a new position in shares of Solventum in the second quarter valued at about $47,000. Ancora Advisors LLC purchased a new position in shares of Solventum in the second quarter valued at about $56,000. Finally, Western Wealth Management LLC bought a new position in shares of Solventum during the first quarter valued at about $58,000.

Wall Street Analyst Weigh In

SOLV has been the subject of a number of analyst reports. Mizuho set a $113.00 target price on shares of Solventum in a report on Thursday, August 6th. Wedbush raised their target price on Solventum from $94.00 to $101.00 and gave the stock an “outperform” rating in a research note on Thursday, August 6th. UBS Group boosted their price target on Solventum from $95.00 to $101.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Zacks Research upgraded Solventum from a “hold” rating to a “strong-buy” rating in a report on Thursday. Finally, Weiss Ratings lowered Solventum from a “buy (b-)” rating to a “hold (c-)” rating in a research report on Monday, November 9th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $90.27.

Read Our Latest Report on Solventum

Solventum Stock Performance

Shares of SOLV stock opened at $88.85 on Monday. The stock has a fifty day moving average of $87.53 and a 200 day moving average of $78.95. Solventum Corporation has a 52 week low of $62.38 and a 52 week high of $94.16. The firm has a market capitalization of $15.08 billion, a price-to-earnings ratio of 99.83, a PEG ratio of 1.27 and a beta of 0.69. The company has a quick ratio of 0.72, a current ratio of 1.03 and a debt-to-equity ratio of 0.99.

Solventum (NYSE:SOLV – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.34 by $0.11. The business had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.93 billion. Solventum had a net margin of 1.91% and a return on equity of 25.03%. The firm’s revenue for the quarter was down 7.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.50 earnings per share. As a group, research analysts expect that Solventum Corporation will post 7.26 earnings per share for the current year.

Solventum Profile

(Free Report)

Solventum is a global healthcare company that develops products and services for hospitals, dental professionals, health systems and other care providers. It was formed from 3M’s healthcare business and became an independent public company in April 2024. The company’s offerings include medical and surgical supplies, wound-care products, sterilization and infection-prevention solutions, dental materials and technologies, and software for health information management. Its products and services support clinical care, dental care and healthcare administration.

Featured Articles

Institutional Ownership by Quarter for Solventum (NYSE:SOLV)

Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.